Abstract
Activity of cytochromes P450 is highly dependent on cytochrome P450 NADPH reductase (P450R), but this enzyme can also metabolise drugs on its own. MDA 231 breast adenocarcinoma cells transfected with human P450R (MDA R4) or an empty vector (MDA EV) were exposed to a series of commonly used chemotherapeutic drugs. Overexpression of P450R did not affect cell sensitivity to cisplatin, mitoxantrone, paclitaxel, docetaxel, vincristine or etoposide. However, MDA R4 cells showed increased sensitivity to mitomycin C (6.6-fold) and also to 5-fluorouracil (2.8-fold). In vitro toxicity assays where mitomycin C, 5-fluorouracil and vincristine were preincubated with microsomes expressing recombinant P450R showed that this effect was not a result of direct metabolism by P450R. Levels of NADPH were considerably decreased in MDA R4 as compared to MDA EV cells, while reactive oxygen species (ROS) production was increased in MDA R4 cells in basal conditions, showing no significant further increase after treatment with mitomycin C or 5-fluorouracil. P450R overexpression appears therefore to be detrimental to MDA 231 cells, depleting NADPH and increasing ROS levels; the increased oxidative stress observed in MDA R4 cells might explain the enhanced...Continue Reading
References
Mar 1, 1991·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·A Martin, M Clynes
Apr 1, 1989·Clinical Pharmacokinetics·R B Diasio, B E Harris
Jul 1, 1971·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·D M ZieglerE M McKee
Dec 1, 1995·Toxicology Letters·H W StrobelS Shen
Oct 6, 1998·Annual Review of Biochemistry·A Jordan, P Reichard
Jan 19, 2000·Current Pharmaceutical Design·P Kovacic, J A Osuna
Sep 22, 2000·Analytical Biochemistry·Z ZhangR C Stanton
Sep 12, 2001·Mutation Research·A SgambatoA Cittadini
Oct 17, 2001·The Journal of Biological Chemistry·A TroyanoP Aller
Oct 9, 2002·Oncogene·Gang Liu, Xinbin Chen
Sep 19, 2003·Biochemical and Biophysical Research Communications·Stephen S LeonardXianglin Shi
Nov 19, 2003·Nitric Oxide : Biology and Chemistry·Peter LorenzThomas F W Horn
Feb 20, 2004·Cancer Research·Rachel L CowenIan J Stratford
Jun 10, 2005·Journal of Biochemistry and Molecular Biology·Sung-Kun YimJae-Gu Pan
Jul 9, 2005·The Breast : Official Journal of the European Society of Mastology·Ramasamy KumaraguruparanSiddavaram Nagini
May 11, 2006·Drug Metabolism Reviews·Bettie Sue Masters, Christopher C Marohnic
Citations
Dec 3, 2013·Acta Pharmacologica Sinica·Monika PawłowskaZofia Mazerska
Jan 11, 2013·Oxidative Medicine and Cellular Longevity·Xiaoyu ChenQiusheng Zheng
May 27, 2010·Molecular Cancer Therapeutics·Yun WangJeffrey D Laskin
Nov 5, 2010·Pharmacogenomics·Junjie FengJianfeng Xu
Oct 23, 2012·Cell Biochemistry and Biophysics·Chao SunZhen-hua Wang
Jul 6, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Natalia A PetushkovaAlexander I Archakov
Dec 27, 2008·Free Radical Biology & Medicine·Defang LiJi Li
Oct 7, 2011·Clinical and Experimental Pharmacology & Physiology·Venkateswaran C PillaiReza Mehvar
Oct 8, 2011·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Chao SunHong Zhang
Oct 29, 2013·Mediators of Inflammation·Xiaoyu ZhangJi Li
Jul 2, 2016·The Journal of Pharmacy and Pharmacology·Lei HuLan Fan
Jul 22, 2017·Pharmacogenetics and Genomics·Liang GongLan Fan
Feb 3, 2012·Archives of Pharmacal Research·Min WangHong Zhang
Aug 26, 2014·Oncotarget·Therese LiechtensteinDavid Escors
Jul 2, 2011·Molecular Biology Reports·Ozlem Darcansoy IşeriUfuk Gündüz
Feb 27, 2018·Dose-response : a Publication of International Hormesis Society·Carmel MothersillColin Seymour
Jan 24, 2021·Journal of Colloid and Interface Science·Deepika AroraBiman B Mandal